Value Set and Code System Information
Code System Name | NullFlavor |
Value Set Code | PHVS_STECNoncultureTestType_BIDS |
Value Set Name | STEC Nonculture Test Type (BIDS) |
Value Set Version | 1 |
Value Set Concept Details
Concept Code | OTH |
Preferred Concept Name | Other |
Value Set Concept Status | Published |
Value Set Concept Status Date | 11/08/2013 |
Value Set Concept Description | |
Sequence |
Code System Concept Details
Code System Concept Name | other |
Code System Concept Status | Published |
Code System Preferred Concept Name | other |
Date Created | |
Date Revised | 05/01/2009 |
Associated Value Sets
Value Set Name | Version(s) | |
---|---|---|
Birth Attendees (NETSS) | 1 | |
AR Agent (RIBD) | 2 , 1 | |
ATI Method (RIBD) | 2 , 1 | |
Acinetobacter culture result (ARLN) | 1 | |
Activity Type (Brucellosis) | 2 , 1 | |
Activity Type (Leptospirosis) | 1 | |
Activity Type Anthrax | 1 | |
Actual Route of Administration (Anthrax) | 1 | |
Acute Illness Complications (Pediatric Flu) | 1 | |
Additional Site of Disease (TB) | 1 | |
Adverse Event Severity (Malaria) | 2 , 1 | |
Age unit | 2 | |
Animal Ownership (Brucellosis) | 2 , 1 | |
Animal Species (Animal Rabies) | 1 | |
Animal Type (Anthrax) | 1 | |
Animal Type (Brucellosis) | 1 | |
Animal Type (COVID-19) | 1 | |
Animal Type (FDD) | 3 , 2 , 1 | |
Animal Type (Leptospirosis) | 2 , 1 | |
Antacids (FDD) | 1 | |
Antibiotic Dose Units (Brucellosis) | 3 , 2 | |
Antibiotic Reason (RIBD) | 1 | |
Antibiotic Received (Pertussis) | 5 , 4 , 3 , 2 , 1 | |
Antibiotic Received (RIBD) | 2 , 1 | |
Antibiotic Treatment (NETSS) | 1 | |
Antibiotics (FDD) | 5 , 4 , 3 , 2 , 1 | |
Antimicrobial Agent (IPD) | 1 | |
Assisted Living Exposure Type (RIBD) | 1 | |
Associated Conditions (NETSS) | 1 | |
Bacterial Infection Syndrome (IPD) | 1 | |
Bacterial Infection Syndrome (NETSS) | 1 | |
Batch Deactivation Reason | 1 | |
Binational Reporting Criteria (BIDS) | 1 | |
Bird Type (RIBD) | 1 | |
Birth Attendant Titles (NCHS) | 3 | |
Birth Attendees (VPD) | 1 | |
Birth Country | 7 , 6 , 5 , 4 | |
Birth Location (Listeria) | 1 | |
Birth Location (RIBD) | 1 | |
Birth Location (VPD) | 1 | |
Birth Outcome (Rubella) | 2 , 1 | |
Birth Outcome (VPD) | 1 | |
Birth or Delivery Occurred (NCHS) | 2 | |
Blood Product | 1 | |
Body Region(s) of Rash | 2 | |
Body Site (FDD) | 1 | |
Botulinum Toxin Type (FDD) | 1 | |
Botulism Food Source Type (FDD) | 1 | |
Brucella Exposure (Brucellosis) | 2 | |
Campylobacter Nonculture Test Type (BIDS) | 1 | |
Case Classification Exposure Source | 2 | |
Case Confirmation Method | 1 | |
Case Detection Method | 3 , 2 , 1 | |
Case Investigation Status | 3 | |
Case Transmission Mode | 2 , 1 | |
Case Transmission Mode (BIDS) | 1 | |
Certifier Titles (NCHS) | 2 | |
Certifier Types (NCHS) | 3 , 2 , 1 | |
Character of Lesions | 2 | |
Cholera Risk Factor (FDD) | 1 | |
Cholera Sequelae (FDD) | 1 | |
Cholera Signs Symptoms (FDD) | 1 | |
Clinical Finding (COVID-19) | 1 | |
Clinical Finding (NNDSS) | 2 | |
Clinical Manifestation (TBRD) | 2 , 1 | |
Clinical Manifestations (Anthrax) | 1 | |
Clinical Manifestations (Babesiosis) | 2 | |
Clinical Manifestations (Brucellosis) | 1 | |
Clinical Manifestations (Leptospirosis) | 2 , 1 | |
Clinical Manifestations (Lyme) | 1 | |
Clinical Outcome (Anthrax) | 1 | |
Clinical Syndrome (Arbovirus) | 7 , 6 , 5 , 4 , 3 , 2 | |
Clinical Syndrome - Secondary (Arbovirus) | 2 , 1 | |
Coinfection Type (TBRD) | 1 | |
College Living Situation (RIBD) | 2 , 1 | |
Common-Source Outbreak (Hepatitis B) | 1 | |
Common-Source Outbreak (Hepatitis C) | 1 | |
Complications (Malaria) | 3 , 1 | |
Complications (Mumps) | 7 , 6 , 5 , 4 | |
Complications (Pertussis) | 3 | |
Complications (TBRD) | 3 , 2 , 1 | |
Contact Type (Anthrax) | 1 | |
Contact Type (Brucellosis) | 1 | |
Contact Type (COVID-19) | 1 | |
Contact Type (FDD) | 1 | |
Contact Type (Hepatitis A) | 1 | |
Contact Type (Hepatitis B and C) | 1 | |
Contact Type (RIBD) | 1 | |
Contact Type Hepatitis A (NETSS) | 1 | |
Country | 6 , 5 , 4 , 3 | |
County | 7 , 6 | |
Critical Infrastructure Sector (NND) | 1 | |
Cruise Line (RIBD) | 1 | |
Cyclosporiasis Signs Symptoms (FDD) | 1 | |
Data Reporting Source (CO) | 2 , 1 | |
Data Reporting Source (COVID-19) | 1 | |
Day Care Setting (FDD) | 1 | |
Death Location (Flu) | 1 | |
Death Reporting Decedent and Certificate Identifier Type (HL70203) (NCHS) | 2 | |
Detection Method (COVID-19) | 2 , 1 | |
Detection Method (RIBD) | 1 | |
Detection Method (STD) | 2 , 1 | |
Diagnosed by (VZ) | 4 , 3 , 2 , 1 | |
Diagnostic Test Finding (Anthrax) | 1 | |
Discharge Location (RIBD) | 3 , 2 , 1 | |
Disease Outcome Type (Leptospirosis) | 1 | |
Disposition ED (NCHS) | 2 | |
Disposition OPD (NCHS) | 1 | |
Division Vital Statistics (County) | 1 | |
Dose Unit (STD) | 3 , 2 , 1 | |
Drinking Water (FDD) | 1 | |
Drugs Used (STD) | 2 , 1 | |
Duration Units (STD) | 2 , 1 | |
E. coli Shiga Toxin (BIDS) | 1 | |
E. coli Shiga Toxin Test Type (BIDS) | 1 | |
Education (CO) | 1 | |
Employment Status (ODH) | 1 | |
Epidemiological Risk Factors (TB) | 6 , 5 , 4 , 3 , 2 , 1 | |
Epilinked Case Type (VZ) | 3 | |
Establishment Type (RIBD) | 1 | |
Ethnicity Group including Unknown | 2 | |
Exposure Location (Brucellosis) | 1 | |
Exposure Risk (EVD) | 1 | |
Exposure Setting (COVID-19) | 2 , 1 | |
Exposure Setting Master (RIBD) | 1 | |
Exposure Site Category (CO) | 4 , 3 , 2 , 1 | |
Exposure Source (Anthrax) | 1 | |
Exposure Source (Brucellosis) | 4 , 3 | |
Exposure Source (CO) | 3 , 2 , 1 | |
Exposure Type (Leptospirosis) | 1 | |
Extended Race Group (Listeria) | 1 | |
Extreme Weather Type (CO) | 4 , 3 , 2 , 1 | |
Fetal Neonatal Infection Type (FDD) | 1 | |
Fetal Neonatal Specimen Type | 1 | |
Fetal Presentations (NCHS) | 3 , 2 | |
Fetal Remains Disposition Method (NCHS) | 1 | |
Follow-up Attempt Outcome (NCHS) | 2 , 1 | |
Food Allergy (Listeria) | 1 | |
Food Cooking Method (FDD) | 1 | |
Food Cooking Method (Trich) | 1 | |
Food Processing Method (FDD) | 1 | |
Food Processing Method (Trich) | 1 | |
Food Product Consumed (Brucellosis) | 2 , 1 | |
Frequency Duration Unit (Hansen) | 2 , 1 | |
Fresh Berries (FDD) | 2 , 1 | |
Fresh Herbs (FDD) | 2 , 1 | |
Fresh Produce (FDD) | 2 , 1 | |
Fresh Water or Mud Type (Leptospirosis) | 2 , 1 | |
Fruit (Listeria) | 1 | |
Gender Identity | 4 , 3 , 2 , 1 | |
Gender Identity (NNDSS) | 1 | |
Gender Identity (USCDI) | 1 | |
Gene Name (CP-CRE) | 4 , 3 , 2 , 1 | |
Gene Name (CPO) | 1 | |
Gene Name (TB) | 2 , 1 | |
Generator Location (CO) | 4 , 3 , 2 , 1 | |
Genotype (Measles) | 1 | |
Genotype (Rubella) | 3 , 2 , 1 | |
Geographic Location | 2 , 1 | |
Geographic Region (NETSS) | 1 | |
Glove Material (RIBD) | 1 | |
H. influenzae Serotype (RIBD) | 1 | |
Health Care Practice Type (TB) | 1 | |
Healthcare Exposure Type (RIBD) | 2 , 1 | |
Healthcare Occupation (COVID-19) | 2 , 1 | |
Hispanic Ethnic Group (Listeria) | 1 | |
Hospital Procedure (Anthrax) | 1 | |
Hospital Procedure (Leptospirosis) | 2 , 1 | |
ICD Codes List (CO) | 4 , 3 , 2 , 1 | |
IgG Test Type (VZ) | 1 | |
IgM Test Type (VZ) | 1 | |
Illness (Listeria) | 2 , 1 | |
Immigration Status | 1 | |
Immunization Funding Source (IIS) | 1 | |
Immunization Information Source (CRS) | 4 , 3 , 2 , 1 | |
Improper Handling Storage (FDD) | 1 | |
Infection Type (RIBD) | 1 | |
Infections During Pregnancy - Live Birth (NCHS) | 4 , 3 , 1 | |
Infections During Pregnancy Fetal Death (NCHS) | 3 , 2 | |
Information Source | 1 | |
Injury Type (NETSS) | 1 | |
Injury Type (VPD) | 1 | |
Insurance Type (RIBD) | 1 | |
Isolate Not Available EIP Test Reason | 1 | |
Isolate Not Received Reason | 1 | |
Isolate Not Sent To NARMS Reason | 1 | |
Job Setting (COVID-19) | 1 | |
LTBI Drug Regimen (TB) | 2 , 1 | |
Lab Result (Babesiosis) | 5 | |
Lab Test (Hansen) | 2 , 1 | |
Lab Test Interpretation (Pertussis) | 5 , 4 , 3 | |
Lab Test Interpretation (RIBD) | 2 , 1 | |
Lab Test Interpretation (VPD) | 7 , 6 , 5 , 4 , 3 , 2 | |
Lab Test Interpretation (Varicella) | 4 , 3 , 2 | |
Lab Test Interpretation Master (RIBD) | 1 | |
Lab Test Method (MDRO) | 3 , 2 , 1 | |
Lab Test Method (RIBD) | 2 , 1 | |
Lab Test Procedure (Measles) | 1 | |
Lab Test Procedure (Mumps) | 1 | |
Lab Test Procedure (Rubella) | 6 , 5 , 4 , 2 , 1 | |
Lab Test Result Coded | 2 | |
Lab Test Result Name | 10 | |
Lab Test Type (Babesiosis) | 2 | |
Lab Test Type (Leptospirosis) | 2 , 1 | |
Lab Test Type (Lyme) | 1 | |
Lab Test Type (Mumps) | 6 , 5 | |
Lab Test Type (Pertussis) | 6 , 5 | |
Language | 3 | |
Legionella Diagnosis (RIBD) | 1 | |
Legionella Exposure (RIBD) | 1 | |
Legionella Exposure Setting (RIBD) | 2 , 1 | |
Legionellosis Serogroup (RIBD) | 2 , 1 | |
Lettuce Type (FDD) | 2 , 1 | |
Location Type (Leptospirosis) | 2 , 1 | |
Manufacturers Of Vaccines (NETSS) | 1 | |
Maternal Infection (FDD) | 1 | |
Meat Consumed Type (Trich) | 1 | |
Meat Purchase Info (FDD) | 1 | |
Meat Purchase Info (Trich) | 1 | |
Medical History (FDD) | 1 | |
Medical History (Listeria) | 1 | |
Medication (Brucellosis) | 1 | |
Medication (Leptospirosis) | 2 , 1 | |
Medication (TB) | 3 , 2 , 1 | |
Medication Administered (Anthrax) | 1 | |
Medication Administered (FDD) | 1 | |
Medication Administered (Hansen) | 1 | |
Medication Frequency Unit (STD) | 2 , 1 | |
Medication Missed (Malaria) | 1 | |
Medication Pre-Treatment (RIBD) | 1 | |
Medication Prophylaxis (Malaria) | 5 , 4 , 3 , 2 , 1 | |
Medication Received (Lyme) | 3 , 2 , 1 | |
Medication Received (TBRD) | 2 , 1 | |
Medication Received (VZ) | 3 , 2 , 1 | |
Medication Route (STD) | 2 | |
Medication Treatment (Babesiosis) | 1 | |
Medication Treatment (Flu) | 2 | |
Medication Treatment (Malaria) | 5 , 4 , 3 , 2 , 1 | |
Medication Treatment (STD) | 1 | |
Methods of Disposition (NCHS) | 2 , 1 | |
Microorganism (ARLN) | 1 | |
Microorganism (NETSS) | 1 | |
Microorganism (Pediatric Flu) | 1 | |
Microorganism (RIBD) | 1 | |
Microorganism (STD) | 1 | |
Microscopic Exam Culture Site (TB) | 3 , 2 , 1 | |
Molecular Test Methods (TB) | 1 | |
N. meningitidis Serogroup (RIBD) | 2 , 1 | |
Neurological Manifestation (STD) | 2 , 1 | |
Non Paint Lead Source | 1 | |
Non Pork Type (FDD) | 1 | |
Non-Sterile Specimen (Pediatric Flu) | 1 | |
Null Flavor (HL7 V3) | 1 | |
Number of Cigarettes Smoked per Day (CO) | 1 | |
Organism (CP-CRE) | 3 , 2 | |
Organism (CPO) | 1 | |
Organism (Lyme) | 2 , 1 | |
Organism (TBRD) | 1 | |
Organism Name (Brucellosis) | 1 | |
Organism Name (Leptospirosis) | 2 , 1 | |
Outdoor Activities | 1 | |
PCR Specimen Source (CRS) | 2 , 1 | |
PCR Specimen Source (VZ) | 3 , 2 , 1 | |
Parotitis Laterality (Mumps) | 2 | |
Patient Case Status (Hansen) | 1 | |
Patient Epidemiological Risk Factors (Hepatitis A) | 5 , 4 , 3 , 2 , 1 | |
Patient Epidemiological Risk Factors (Hepatitis B) | 6 , 5 , 4 , 3 , 2 | |
Patient Epidemiological Risk Factors (Hepatitis C) | 5 , 4 , 3 , 2 , 1 | |
Patient Type (Listeria) | 2 | |
Performing Lab Type (Anthrax) | 1 | |
Performing Lab Type (RIBD) | 1 | |
Performing Lab Type (Trich) | 1 | |
Performing Laboratory Type (Leptospirosis) | 1 | |
Performing Laboratory Type (VPD) | 1 | |
Person/Organization Taking CO Reading (CO) | 1 | |
Personal Protective Equipment (RIBD) | 1 | |
Place of Death (NCHS) | 4 , 3 , 2 | |
Poison Control Center Record (CO) | 2 , 1 | |
Pork Type (FDD) | 1 | |
Pregnancy Outcome (FDD) | 1 | |
Pregnancy Outcome (Leptospirosis) | 1 | |
Pregnancy Outcome (Listeria) | 2 , 1 | |
Previous Case Diagnosed By (Rubella) | 2 , 1 | |
Previous Treatment Duration (Hansen) | 1 | |
Primary Reason For Evaluation (TB) | 3 , 2 | |
Procedure Type (Anthrax) | 1 | |
Public Site of Exposure (CO) | 4 , 3 , 2 , 1 | |
Public TransportationType (Anthrax) | 1 | |
Rash Location First Noted (VZ) | 1 | |
Raw Unpasteurized Products (FDD) | 1 | |
Reason For Test (Hepatitis) | 2 , 1 | |
Reason LTBI Not Started (TB) | 2 , 1 | |
Reason LTBI Treatment Stopped (TB) | 1 | |
Reason Medication Not Completed (BSP) | 1 | |
Reason Not Interviewed (Listeria) | 1 | |
Reason Not Treated with RIPE (TB) | 3 , 2 , 1 | |
Reason Therapy Stopped (TB) | 3 , 2 , 1 | |
Reason for Hospitalization (VZ) | 3 , 2 , 1 | |
Reason for Test (COVID-19) | 1 | |
Recreational Water (FDD) | 1 | |
Relationship (Hansen) | 2 , 1 | |
Relationship (VPD) | 1 | |
Reporting Lab Type | 1 | |
Reporting Source Type | 2 | |
Residence Location (RIBD) | 3 , 2 , 1 | |
Residence Type (COVID-19) | 1 | |
Residential Site of Exposure (CO) | 3 , 2 , 1 | |
Respiratory Protective Equipment (RIBD) | 1 | |
Risk Factor (COVID-19) | 3 , 2 , 1 | |
Risk Factors (TB) | 1 | |
Rodent Type (Leptospirosis) | 1 | |
Route Of Administration (IIS) | 2 | |
Route of Administration (STD) | 2 , 1 | |
SPN/IPD Serotype (RIBD) | 2 , 1 | |
STEC Nonculture Test Type (BIDS) | 1 | |
Salmonella Serogroup (BIDS) | 1 | |
School Year (RIBD) | 1 | |
Seafood Preparation (FDD) | 2 , 1 | |
Seafood Purchase Info (FDD) | 1 | |
Seafood Source (FDD) | 1 | |
Seafood Type (FDD) | 3 | |
Sequelae (RIBD) | 2 , 1 | |
Serogroup (NETSS) | 1 | |
Serogroup Method (RIBD) | 1 | |
Serotype (NETSS) | 1 | |
Serotype Master (RIBD) | 1 | |
Serotype Method (RIBD) | 1 | |
Setting of Further Spread | 1 | |
Severe Weather Type (Leptospirosis) | 2 | |
Sexual Orientation | 2 , 1 | |
Sexual Orientation (STD) | 1 | |
Sexual Orientation (USCDI) | 1 | |
Shellfish Distributed (FDD) | 1 | |
Sick Animal Type (Leptospirosis) | 1 | |
Side Effect of Treatment (TB) | 1 | |
Signs Symptoms (CS) | 1 | |
Signs and Symptoms (CO) | 1 | |
Signs and Symptoms (COVID-19) | 2 , 1 | |
Signs and Symptoms (FDD) | 2 , 1 | |
Signs and Symptoms (Hepatitis) | 1 | |
Signs and Symptoms (Listeria) | 1 | |
Signs and Symptoms (Measles) | 3 | |
Signs and Symptoms (Mumps) | 3 , 2 | |
Signs and Symptoms (Pertussis) | 4 | |
Signs and Symptoms (RIBD) | 2 , 1 | |
Signs and Symptoms (Rubella) | 3 | |
Signs and Symptoms (Trich) | 1 | |
Skin Exposure Activity (FDD) | 1 | |
Source of Laboratory Test (Hepatitis) | 3 , 2 , 1 | |
Species (Malaria) | 1 | |
Specimen | 13 | |
Specimen (Flu) | 2 , 1 | |
Specimen Collection Setting Type (C. auris) | 2 , 1 | |
Specimen Collection Site AST (STD) | 1 | |
Specimen Collection Source (FDD) | 3 , 2 , 1 | |
Specimen Reshipment Reason | 1 | |
Specimen Site (BIDS) | 1 | |
Specimen Site (FDD) | 1 | |
Specimen Source (C. auris) | 1 | |
Specimen Source (CP-CRE) | 1 | |
Specimen Source (CRS) | 2 , 1 | |
Specimen Source (Measles) | 1 | |
Specimen Source (Mumps) | 1 | |
Specimen Source (Rubella) | 2 , 1 | |
Specimen Source (STD) | 2 , 1 | |
Specimen Source (VPD) | 1 | |
Specimen Source Site (Anthrax) | 1 | |
Specimen Source Site (Brucellosis) | 1 | |
Specimen Source Site (Leptospirosis) | 1 | |
Specimen Source Site (VPD) | 1 | |
Specimen Type (Anthrax) | 1 | |
Specimen Type (Brucellosis) | 1 | |
Specimen Type (CRS) | 2 , 1 | |
Specimen Type (Leptospirosis) | 2 , 1 | |
Specimen Type (Listeria) | 1 | |
Specimen Type (Lyme) | 2 , 1 | |
Specimen Type (Malaria) | 2 , 1 | |
Specimen Type (RIBD) | 4 , 3 , 2 , 1 | |
Specimen Type (Rubella) | 2 , 1 | |
Specimen Type (TBRD) | 1 | |
Specimen Type AST (STD) | 1 | |
Specimen type (ARLN) | 1 | |
Specimen type (Trich) | 1 | |
Sputum Culture Conversion Not Documented Reason | 2 , 1 | |
Sterile Specimen (IPD) | 2 , 1 | |
Sterile Specimen (Pediatric Flu) | 1 | |
Strain Type (Trich) | 3 , 2 , 1 | |
Substance Abuse (RIBD) | 3 , 2 , 1 | |
Substance Treatment Refusal Reason | 1 | |
Susceptibility Data NA (RIBD) | 1 | |
Susceptibility Test Method (TB) | 1 | |
Swimming Pool Type (FDD) | 1 | |
Symptoms (EVD Triage) | 1 | |
Syphilis Clinical Stage (CS) | 1 | |
Syphilis Surveillance Stage (CS) | 2 , 1 | |
Syphilis Treatment Mother (CS) | 1 | |
Tap Water Source (FDD) | 1 | |
Tattoo Obtained From (Hepatitis) | 2 , 1 | |
Test Method (FDD) | 4 , 3 , 2 | |
Test Method EIA IgM | 1 | |
Test Results (Leptospirosis) | 1 | |
Test Results Anthrax | 1 | |
Test Titer Type (Brucellosis) | 1 | |
Test Type (Brucellosis) | 2 , 1 | |
Test Type (FDD) | 2 , 1 | |
Therapy Extended Reason (TB) | 3 , 2 , 1 | |
Timing of Maternal Treatment (NND) | 2 | |
Titer Test Method (RIBD) | 1 | |
Transmission Setting (NETSS) | 1 | |
Transmission Setting (NND) | 3 , 2 , 1 | |
Transportation Relationships (NCHS) | 2 | |
Travel Purpose | 2 , 1 | |
Travel Purpose (CDC) | 1 | |
Travel Reason (Hepatitis A) | 1 | |
Travel Reason (Malaria) | 4 , 3 , 2 , 1 | |
Travelers Health Info Source | 1 | |
Treatment Type (Anthrax) | 1 | |
Treatment Type (CO) | 1 | |
Treatment Type (COVID-19) | 2 , 1 | |
Treponemal Serologic Test (STD) | 2 , 1 | |
Tribe Name (NND) | 2 , 1 | |
Trichinellosis Signs Symptoms (FDD) | 1 | |
Type Of Complication (CRS) | 4 , 3 , 2 , 1 | |
Type Of Complication (Rubella) | 4 , 3 , 2 , 1 | |
Type of Co-infection (C. auris) | 2 , 1 | |
Type of Complication (Babesiosis) | 1 | |
Type of Complication (Measles) | 2 , 1 | |
Type of Complication (STD) | 2 , 1 | |
Type of Complication (VZ) | 2 | |
Type of Correctional Facility | 3 , 2 | |
Type of Deafness (Mumps) | 2 | |
Type of Leprosy (Hansen) | 2 , 1 | |
Type of Link (TB) | 1 | |
Type of Long Term Care Facility | 3 , 2 | |
Type of Long Term Care Facility (C. auris) | 1 | |
Type of Radiology Study | 1 | |
Type of Testing at CDC | 2 , 1 | |
Type of Testing at CDC (NND) | 1 | |
Type of Testing at CDC (VZ) | 1 | |
Type of Testing at CDC(Rubella) | 1 | |
Typhoid Signs Symptoms (FDD) | 1 | |
Underlying Condition (RIBD) | 2 , 1 | |
Underlying Condition(s) (Leptospirosis) | 2 , 1 | |
Underlying Conditions | 1 | |
Underlying Conditions (CO) | 3 , 2 , 1 | |
Underlying Conditions (IPD) | 2 , 1 | |
Underlying Conditions (Pediatric Flu) | 1 | |
Usual Occupation and Industry (TB) | 1 | |
VPD Laboratory Coded Observation | 1 | |
VPD Specimen Type | 6 , 5 , 4 | |
Vaccination Information Source (RIBD) | 2 , 1 | |
Vaccination Location (CRA) | 1 | |
Vaccine Administered (MMR) | 2 | |
Vaccine Administered (Pertussis) | 2 | |
Vaccine Event Information Source (NND) | 3 , 2 , 1 | |
Vaccine Exposure (Brucellosis) | 1 | |
Vaccine Not Given Reason | 3 , 2 , 1 | |
Vaccine Not Given Reasons (NETSS) | 1 | |
Vaccine Purchased With Funds | 1 | |
Vaccine Type (NND) | 13 , 12 , 11 , 10 , 9 , 8 , 7 , 6 , 5 , 4 , 3 , 2 | |
Vaccine Type (RIBD) | 2 , 1 | |
Vaccines Administered (NETSS) | 1 | |
Vaccines Administered (VZ) | 2 | |
Vibrio Cholera Toxin Test Type (BIDS) | 1 | |
Vibrio Culture Species (BIDS) | 1 | |
Vibrio Species (FDD) | 3 , 2 , 1 | |
Virus Variant Type (Animal Rabies) | 2 , 1 | |
Water Salinity (FDD) | 1 | |
Water Source (RIBD) | 1 | |
Work Schedule (ODH) | 1 | |
Workers Compensation Record (CO) | 2 , 1 |